Patents by Inventor Lynn Hlatky

Lynn Hlatky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TUMOR-INITIATING CELLS AND METHODS OF USE
    Publication number: 20150135341
    Abstract: Provided herein are an isolated or enriched population of tumor initiating cells derived from normal cells, cells susceptible to neoplasia, or neoplastic cells. Methods of use of the cells for screening for anti-hyperproliferative agents, and use of the cells for animal models of hyperproliferative disorders including metastatic cancer, diagnostic methods, and therapeutic methods are provided.
    Type: Application
    Filed: January 31, 2014
    Publication date: May 14, 2015
    Applicant: GENESYS RESEARCH INSTITUTE
    Inventor: Lynn Hlatky
  • Tumor-initiating cells and methods of use
    Patent number: 8679835
    Abstract: Provided herein are an isolated or enriched population of tumor initiating cells derived from normal cells, cells susceptible to neoplasia, or neoplastic cells. Methods of use of the cells for screening for anti-hyperproliferative agents, and use of the cells for animal models of hyperproliferative disorders including metastatic cancer, diagnostic methods, and therapeutic methods are provided.
    Type: Grant
    Filed: June 30, 2009
    Date of Patent: March 25, 2014
    Assignee: GeneSys Research Institute
    Inventor: Lynn Hlatky
  • TUMOR-INITIATING CELLS AND METHODS OF USE
    Publication number: 20100162419
    Abstract: Provided herein are an isolated or enriched population of tumor initiating cells derived from normal cells, cells susceptible to neoplasia, or neoplastic cells. Methods of use of the cells for screening for anti-hyperproliferative agents, and use of the cells for animal models of hyperproliferative disorders including metastatic cancer, diagnostic methods, and therapeutic methods are provided.
    Type: Application
    Filed: June 30, 2009
    Publication date: June 24, 2010
    Applicant: Caritas St. Elizabeth Medical Center of Boston, Inc.
    Inventor: Lynn Hlatky
  • Generation and use of vasculogenic tumors and products derived from same
    Patent number: 7638273
    Abstract: Tumors can be directed into a vasculogenic program and used to regenerate tissues in a verterbrate host, identify factors originating from the tumor that are useful for tissue regeneration, and to generate such factors for use in a subject apart from the tumor itself.
    Type: Grant
    Filed: October 18, 2006
    Date of Patent: December 29, 2009
    Assignee: Caritas St. Elizabeth's Medical Center of Boston, Inc.
    Inventors: Philip Hahnfeldt, Lynn Hlatky
  • Generation and use of vasculogenic tumors and products derived from same
    Publication number: 20070098637
    Abstract: Tumors can be directed into a vasculogeinc program and used to regenerate tissues in a verterbrate host, identify factors originating from the tumor that are useful for tissue regeneration, and to generate such factors for use in a subject apart from the tumor itself.
    Type: Application
    Filed: October 18, 2006
    Publication date: May 3, 2007
    Applicant: Caritas St. Elizabeth's Medical Center of Boston, Inc.
    Inventors: Philip Hahnfeldt, Lynn Hlatky